Manufacturing of recombinant human follicle-stimulating hormone Ovaleap® (XM17): comparability to Gonal-f®, formulation, and stability

被引：0
|
作者：
Weiss, Herman [1 ]
Winstel, Rainer [2 ]
Allgaier, Hermann [2 ]
Wieland, Juergen [2 ]
Mueller, Arnd [2 ]
机构：
[1] Teva Global Med Affairs, Petah Tiqwa, Israel
[2] Merckle GmbH, Ulm, Germany
来源：
GYNECOLOGICAL ENDOCRINOLOGY | 2016年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P195
引用
收藏
页码：146 / 147
页数：2
相关论文
共 50 条
  • [1] Manufacturing of recombinant human follicle-stimulating hormone Ovaleap (R) (XM17): comparability to Gonal-f (R), formulation, and stability
    Weiss, H.
    Winstel, R.
    Allgaier, H.
    Wieland, J.
    Mueller, A.
    [J]. GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2016, 38 (01): : 226 - 226
  • [2] Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap® (XM17), Comparability with Gonal-f®, and Performance/Consistency
    Rainer Winstel
    Juergen Wieland
    Beate Gertz
    Arnd Mueller
    Hermann Allgaier
    [J]. Drugs in R&D, 2017, 17 : 305 - 312
  • [3] Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap® (XM17), Comparability with Gonal-f®, and Performance/Consistency
    Winstel, Rainer
    Wieland, Juergen
    Gertz, Beate
    Mueller, Arnd
    Allgaier, Hermann
    [J]. DRUGS IN R&D, 2017, 17 (02) : 305 - 312
  • [4] Immunogenicity assessment of Ovaleap® (XM17) recombinant human follicle-stimulating hormone in infertile women undergoing assisted reproductive technology (ART)
    Zou, Linglong
    Mueller, Arnd
    Gertz, Beate
    Weiss, Herman
    Liu, Patrick
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 147 - 147
  • [5] Immunogenicity assessment of Ovaleap (R) (XM17) recombinant human follicle-stimulating hormone in infertile women undergoing assisted reproductive technology (ART)
    Zou, L.
    Mueller, A.
    Gertz, B.
    Weiss, H.
    Liu, P.
    [J]. GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2016, 38 (01): : 233 - 233
  • [6] Jaundice after induced ovulation by human recombinant follicle stimulating hormone (Gonal-f®)
    Bumsel, Franck
    Causse, Xavier
    Bensouda-Grimaldi, Lamiae
    Megier, Pascal
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 (12): : 1408 - 1409
  • [7] The effect of recombinant follicle stimulating hormone (Gonal-F) on endogenous luteinizing hormone secretion in women
    Hull, ML
    Livesey, JH
    Evans, JJ
    Benny, PS
    [J]. HUMAN REPRODUCTION, 1998, 13 (05) : 1139 - 1143
  • [8] Phase I, two-way, crossover study to demonstrate bioequivalence and to compare safety and tolerability of single-dose XM17 vs Gonal-f® in healthy women after follicle-stimulating hormone downregulation
    Lammerich, Andreas
    Mueller, Arnd
    Bias, Peter
    [J]. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2015, 13
  • [9] Phase I, two-way, crossover study to demonstrate bioequivalence and to compare safety and tolerability of single-dose XM17 vs Gonal-f® in healthy women after follicle-stimulating hormone downregulation
    Andreas Lammerich
    Arnd Mueller
    Peter Bias
    [J]. Reproductive Biology and Endocrinology, 13
  • [10] Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women
    Lammerich, Andreas
    Bias, Peter
    Gertz, Beate
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2015, 7 : 707 - 715
12345